Alnylam Pharmaceuticals
ALNY
#690
Rank
S$48.22 B
Marketcap
S$361.17
Share price
-2.12%
Change (1 day)
-8.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company